Gapping up
In reaction to strong earnings/guidance:
- STNE +24.3%, HEI +10.6%, OOMA +9.2%, TSCO +6% (guides Q2 well above consensus),VIPS +5.1%, PZZA +3.8% (May comps)
Other news:
- MRSN +32.4% (reports "positive" interim data from the expansion portion of the XMT-1536 Phase 1 Study
- CHRS +9.1% (to join S&P SmallCap 600)
- ZYNE +8.2% (announces "positive" top line results from exploratory open label Phase 2 BRIGHT Trial of Zygel in autism spectrum disorder)
- ESNT +6.7% (to join S&P MidCap 400)
- TSCO +6.1% (issues upside revenue and EPS guidance for Q2)
- PTEN +5.5% (to join S&P SmallCap 600)
- ATRA +4.7% (prices offering of 12,633,039 shares of its common stock at $11.32 per share and, to certain investors, pre-funded warrants to purchase 2,866,961 shares of common stock at $11.3199 per pre-funded warrant share)
- BAM +3.2% (BEP and BAM announce offering of 10,236,000 limited partnership units of BEP by certain affiliates of BAM)
- DIS +2.5% (to submit proposal on Wed concerning phased reopening of Florida parks)
- TLRY +1.8% (announces optimization plan for adult-use facilities in Canada)
- DPZ +1.3% (provides mid-quarter update; co is seeing a material increase in US comps in weeks 5-8 of Q2 relative to weeks 1-4)
- IDXX +1.1% (provides update on US Companion Animal Market Trends through May 22), .
Analyst comments:
- AMC +5.9% (upgraded to Neutral from Sell at MKM Partners)
- NYMT +4.7% (upgraded to Equal Weight from Underweight at Barclays)
- HIBB +4.2% (upgraded to Positive from Neutral at Susquehanna)
- XRAY +2% (upgraded to Outperform from In-line at Evercore ISI)